Regeneron Pharmaceuticals Inc (REGN) is trading at $798.17 up 1.70% over the past 24 hours. Its Galaxy Score is 79.9, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 35.2K engagements and 42 posts with 96% positive social sentiment.
LunarCrush tracks live social sentiment, mentions, news, and influencer activity for Regeneron Pharmaceuticals Inc (REGN) across X, Reddit, StockTwits, YouTube, and news. Follow how conversation around REGN is shifting alongside price, Galaxy Score, social dominance, market cap, and 24-hour engagements and mentions. This is the social intelligence snapshot for Regeneron Pharmaceuticals Inc (REGN): who is talking, how they feel, and how loud the conversation is right now. Numbers update throughout the day as new posts, news headlines, and creator activity land. Read this page as the Regeneron Pharmaceuticals Inc (REGN) briefing: live market context, social volume, and the tone of the conversation in one snapshot.
AI summary: Regeneron Pharmaceuticals (REGN) is a biotech stock driven by Ebola momentum, rare disease drug approvals, and concerns over upcoming melanoma trial results. Price is near 52-week highs with a slight pullback (-0.84% 24h), supported by FDA approval and social enthusiasm, but weighed down by melanoma readouts.